Keren Rouvinov

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

Thomas Powles, Tibor Csőszi, Mustafa Özgüroğlu et al. · The Lancet Oncology · 2021 · 627 citations · Full text

First-line Therapy, Urology, Chemotherapy Versus Chemotherapy +7

Active Smoking May Negatively Affect Response Rate, Progression-Free Survival, and Overall Survival of Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib

Daniel Keizman, Maya Gottfried, Maya Ish‐Shalom et al. · The Oncologist · 2013 · 63 citations · Full text

A Study of Inflammation-Based Predictors of Tumor Response to Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

Mark Krauthamer, Keren Rouvinov, Samuel Ariad et al. · Oncology · 2013 · 55 citations

Imaging response during therapy with radium-223 for castration-resistant prostate cancer with bone metastases—analysis of an international multicenter database

Daniel Keizman, M Ø Fosboel, Hermann Reichegger et al. · Prostate Cancer and Prostatic Diseases · 2017 · 46 citations

Engineering, Oncologic Imaging, Medical Imaging +13

Functional binding of PD1 ligands predicts response to anti-PD1 treatment in patients with cancer

Bar Kaufman, Orli Abramov, Anna Ievko et al. · Science Advances · 2023 · 38 citations · Full text